Finweek - English

DOUBLE TAKE

THE GOOD

SE-listed Blue Label Telecoms and Sasol made bold strides in executive accountability for non-performance. Blue Label executives were hit with pay cuts for failing to meet a number of targets in the last The board of Blue Label (which holds a 45% stake in Cell C), were “extremely disappointed” in the performance of Cell C, which largely contributed to Blue Label’s R6.6bn loss. Joint CEOs Brett and Mark Levy, who both took home R23.9m in 2018, had their remuneration cut 40% to R14.3m in 2019. Meanwhile Sasol showed it’s joint CEOs, Stephen Cornell and Bongani Nqwababa, the door in “an amicable mutual separation” following shortcomings in the execution of the Lake Charles Chemical Project, said Sasol in a statement.

You’re reading a preview, subscribe to read more.

More from Finweek - English

Finweek - English3 min read
Keep On Keeping It Simple
recently I had a Covid-19-compliant coffee with some investors who’d started investing around ten years ago. We were chatting about stocks, market crashes and the like but then the conversation took an interesting turn. I asked what they believed to
Finweek - English6 min read
The A-Z Of Investments
On 1 November, South Africans took to voting stations to cast their votes in the municipal elections. However, the result was not what either the ANC or the DA had hoped for, with 46% of the country having supported the ANC and 22% the DA. This is a
Finweek - English2 min read
A Rise In Buying Interest
established and listed on the JSE in 1996, Netcare is the third-largest private hospital operator by market value in SA. It employs just over 21 000 people, with 51 hospitals, 10 605 registered beds and 422 theatres. Netcare has managed to retain fir

Related Books & Audiobooks